نوع مقاله : مقاله پژوهشی
نویسندگان
1 دانشکده مهندسی، گروه مهندسی برق، واحد همدان ،دانشگاه آزاد اسلامی ، همدان، ایران
2 دانشکده مهندسی، گروه مهندسی مکانیک، واحد همدان ،دانشگاه آزاد اسلامی ، همدان، ایران
چکیده
کلیدواژهها
عنوان مقاله [English]
Magnetic fluid hyperthermia is a new subclass of cancer treatment in which super-paramagnetic nanoparticles injected or diffused in cancerous tissue while exposing alternating magnetic field. The aim of this study is to scrutinize the effects of nanoparticles’concentration, resonance frequency, the coil’s resonance frequency and time as well as the magnetic field intensity on A-549 human lung cancer line.In this study, after culturing A-549 human lung cancer line, the four different nanoparticles’ diameters at three different frequencies, three different magnetic field intensities and four concentrations of nanoparticles were arranged to study the importance of them whilst a series of the three coils was designed to produce magneticHaving weighed the importance of parameters including the resonance coil’s frequency, nanoparticles’ resonance frequency and sizes, nanoparticles concentrations, the magnetic field intensity and iron uptake of cell line, we are inclined to believe that these parameters play a pivotal role in the hyperthermic temperature difference whilst this temperature difference equal to 5±0.5 0C can able to kill al cancerous A-549 cells.
[1]. Baronzio GF, Hager ED. Hyperthermia in cancer treatment: a primer. : Springer Science & Business Media, 2008.
[2]. Byrne JD, Betancourt T, Brannon-Peppas LJAddr. Active targeting schemes for nanoparticle systems in cancer therapeutics. 2008; 60: 1615-26.
[5]. Bakoglidis K, Simeonidis K, Sakellari D, et al. Size-dependent mechanisms in AC magnetic hyperthermia response of iron-oxide nanoparticles. 48,1320-3, 2012.
[6]. Azarmi S, Roa WH, Löbenberg RJAddr. Targeted delivery of nanoparticles for the treatment of lung diseases. 60, 863-75, 2008.
[7]. Hilger I, Hergt R, Kaiser WAJIr. Effects of magnetic thermoablation in muscle tissue using iron oxide particles: an in vitro study. 35, 170-9, 2000.
[8]. Fortin J.P, Wilhelm C, Servais J, et al. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. 2007; 129: 2628-35.
[9]. Meng Lin M, Kim H-H, Kim H, et al. Iron oxide-based nanomagnets in nanomedicine: fabrication and applications. 1, 4883, 2018.
[10]. Zhang P, Ren Z, Chen Z, et al. Iron oxide nanoparticles as nanocarriers to improve chlorin e6-based sonosensitivity in sonodynamic therapy, 12, 4207, 2018.
[11]. Attar MM, Amanpour S, Haghpanahi M, et al. Thermal analysis of magnetic nanoparticle in alternating magnetic field on human HCT-116 colon cancer cell line. 32, 858-67, 2016.
[12]. Matsumine A, Kusuzaki K, Matsubara T, et al. Novel hyperthermia for metastatic bone tumors with magnetic materials by generating an alternating electromagnetic field. 24, 191-200, 2007.
[13]. Shubitidze F, Kekalo K, Stigliano R, Baker IJJoap. Magnetic nanoparticles with high specific absorption rate of electromagnetic energy at low field strength for hyperthermia therapy. 117,094302-094312, 2015.
[14]. Abbott JJJRosi. Parametric design of tri-axial nested Helmholtz coils. 86, 054701-054710, 2015.
[15]. Colak I, Kabalci E, Bayindir R. Review of multilevel voltage source inverter topologies and control schemes1,114-28, 2011.
[16]. Rajesh B, cp M. Comparison of harmonics and THD suppression with three and 5 level multilevel inverter-cascaded H-bridge. 1-6. 2016.
[17]. Shigeno A, Koizumi HJIToPE. Voltage-Source Parallel Resonant Class E Inverter. 2019.
[18]. Murakami S, Kobayashi R, Nakagawa A, et al. Resonant inverter.: Google Patents, 2020.
[19]. Attaluri A, Jackowski J, Sharma A, et al. Design and construction of a Maxwell-type induction coil for magnetic nanoparticle hyperthermia. 37, 1-14. 2020.
[20]. Spoo T, McCammon D, Gruenke R, Melton C. Application of Helmholtz Coils in X-ray Instrumentation. American Astronomical Society 233, 32-40,2019.
[21]. Cooper S, Spiro SGJR. Small cell lung cancer: treatment review. 11, 241-8. 2006.
)
